Nanotechnology in the Development of Drug-Resistant Cancer Treatments

Abstract

The development of drug-resistant cancer therapies remains a major challenge in oncology. Nanotechnology, with its potential to revolutionize cancer treatment, offers innovative solutions to overcome drug resistance. This article explores the role of nanotechnology in the development of drug-resistant cancer treatments, focusing on the mechanisms of drug resistance, the application of nanocarriers, and the targeted delivery systems that enhance the efficacy of existing chemotherapy agents. Through the use of nanoparticles and nanomaterials, it is possible to improve the bioavailability of drugs, bypass biological barriers, and reduce side effects, which contribute to better treatment outcomes. Furthermore, nanotechnology can enable precise targeting of cancer cells, ensuring minimal damage to healthy tissue while combating resistant strains of cancer cells. The article discusses current research, technological advancements, and the future potential of nanotechnology in overcoming drug resistance in cancer treatments.